Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+urothelial cancer at high risk for recurrence Meeting Abstract
| Authors: | Bajorin, D. F.; Gomella, L. G.; Sharma, P.; Plimack, E. R.; O'Donnell, P. H.; Hoffman-Censits, J. H.; Flaig, T. W.; Quinn, D. I.; Campogan, D.; Haynes, H.; McCoy, C.; Maher, J.; DeVries, T.; Sheikh, N. A.; Lerner, S. P. |
| Abstract Title: | Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+urothelial cancer at high risk for recurrence |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203346 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4541 |
| Notes: | Meeting Abstract: 4541 -- Source: Wos |
